This ASX infant formula share just reported explosive growth. Could it be the next a2 Milk?

Could Nuchev Ltd (ASX: NUC) become the next A2 Milk Company Ltd (ASX: A2M)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Nuchev Ltd (ASX: NUC) shares are up 3.79% today on the release of a strong quarterly report this morning. A relatively new ASX infant formula player, Nuchev is an Australian based, globally orientated food business with a dedicated focus on developing, marketing and selling a range of premium Australian-made goat nutritional products.

Nuchev's primary products include its Oli6 branded goat infant formula and nutritional range, which are sold across multiple sales channels in Australia, China and Hong Kong. 

Explosive quarterly report 

Earlier today, Nuchev provided a 3rd quarter activity report for the period ending 31 March 2020. It highlighted continued sales momentum of its Oli6 goat-milk infant formula and nutritional products, with significant revenue and volume growth across key distribution channels. 

Despite the coronavirus pandemic, the company delivered all-time record sales and an all-time record sales month in March 2020. It notes that it has not experienced any adverse material impacts as a result of COVID-19 and that the strong market demand has been capably met by Nuchev's supply chain. 

Volumes and net revenue for the 9 months ending March 2020 increased by approximately 168% and 155%, respectively, on the previous corresponding period (pcp). Its revenue during this period soared from $5.1 million in the pcp to $13.0 million. Nuchev currently has a market capitalisation just shy of $100 million, which places the company at a relatively low sales multiple. 

Its sales momentum is driven by its key sales channels of cross border e-commerce, pharmacy and grocery partners. Nuchev submitted its brand application to sell Chinese specification Oli6 product in the offline channel to the State Administration for Market Regulation (SAMR) in 2018. It notes that some brands manufactured in Europe recently received approval, and remains confident that the process will progress to a positive outcome. Should it receive approval, investors can expect a significant volume and revenue boost.

Given Nuchev's recent IPO, the company is in a strong cash position with $13 million cash on hand with no debt. The company is showing improvements in its cash flows but still operating at a loss. 

Could it be the next A2 Milk?

The A2 Milk Company Ltd (ASX: A2M) had similar humble beginnings. However, Nuchev's strong performance today is by no means a guarantee that it will become an infant formula giant. One of my personal criticisms is that goat milk is a niche market and not all consumers may be inclined to consume goat-milk related products. The market opportunity at hand may be smaller than cows milk. 

That said, Nuchev is making a move in the right direction. The company has achieved very strong growth results with no significant supply chain issues amidst all this chaos. The SAMR application approval could serve as a catalyst for its revenues and share price to reach new highs, however there is an inherent risk as it could be rejected/delayed. Overall, I believe it has potential and is a stock worth having on your watchlist. 

Motley Fool contributor Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »